Myopathy General
NMJ Disorders
Dystrophies
Myositis/Myopathy
Treatment
100

What kind of test has a high diagnostic value in most acquired muscle diseases?

Muscle Biopsy

100

Most common presenting symptom of NMJ disorder in neonates

Hypotonia

100

Age group of presentation of Becker Muscular Dystrophy

Adolescence/Adulthood

100

Dermatomyositis pathological finding

Perifascicular atrophy

100

Thymectomy is recommended for patients with generalized AChR-positive Myasthenia gravis up to age xx?

65

200

Which test has replaced muscle biopsy for diagnostic purposes for many inherited myopathies?

Genetic testing

200

In patients with MG, antibody-mediated autoimmune attack is ??xxxxx?? dependent and results from loss of self-tolerance in the thymus

 T-cell

200

Gene affected in Myotonic Dystrophy DM1

CTG repeat at DMPK gene

200

This disorder is characterized by episodic muscle weakness triggered by changes in serum potassium

Periodic paralysis

200

Monoclonal antibody targeting complement C5 is FDA-approved for refractory generalized MG

Eculizumab (Soliris)

300

True or False?

Extraocular muscles are more frequently involved in patients with inherited myopathies

True

300

This electrophysiological technique is the most sensitive for detecting neuromuscular transmission failure, but has limited specificity

SFEMG- Single fiber electromyography

300

This dystrophy characteristically present with contractures at the elbows, ankles and neck

Emery Dreifuss

300

This neuromuscular disorder can present with both myopathic and neurogenic features on EMG, complicating the diagnosis

Inclusion body myositis

300

This complement inhibitor, approved in 2024, is indicated for AChR Ab-positive generalized MG

Ravulizumab (Ultomiris)

400

A muscular disease which known for fatal cardiac arrhythmias and sudden death

LMNA muscular dystrophy

400

Lambert-Eaton Syndrome EMG findings?

Decremental response on low frequency RNS and an incremental response on high-frequency RNS

400

Clinical phenomena that can differentiate myotonia congenita from paramyotonia congenita

Warm up phenomena

400

This clinical sign, seen in infants with SMA, is due to relative sparing of the diaphragm

Paradoxical inspiratory movement (bell shaped chest)

400

Novel therapy for Duchenne that targets increasing the baseline percentage of normal dystrophin protein

Exon skipping therapy

500

A novel noninvasive imaging system that can detect muscle degeneration

Multispectral optoacoustic tomography

500

Mediators of acetylcholine receptor clustering on the postsynaptic membrane

Muscle-specific kinase [MuSK] 

and 

Low-density lipoprotein receptor-related protein 4

500

Dystophy with prominent upper arm weakness with relative sparing of the deltoids.

FSHD (Fascioscapulohumeral muscular dystrophy)

500

Myopathy associated with malignant hyperthermia

Central core myopathy (RYR1)

500

This subcutaneous complement inhibitor was FDA-approved in 2025 for AChR Ab-positive generalized MG

Zilucoplan (Zilbrysq)